Newly identified genes impact how transplanted stem cells give rise to blood cells

February 16, 2016, St. Jude Children's Research Hospital

A team of researchers led by scientists at St. Jude Children's Research Hospital is looking at ways to improve how blood-forming stem cells can be used for therapeutic interventions. The work has uncovered a group of genes that regulate how hematopoietic stem cells start to grow and thrive in mice. The function of many of these genes was previously unknown. Reconstitution of a robust blood-forming system is essential for recovery from many catastrophic diseases as well as from chemotherapy treatments. A report on this study appears today in the Journal of Experimental Medicine.

Hematopoietic stem cell transplantation is the only therapy that cures many catastrophic malignancies linked to bone marrow or immune system failure. However, generating sufficient quantities of viable stem cells for this type of intervention is immensely challenging. Despite efforts to increase the yield of , the viability of these cells in culture remains a problem. As an alternative to this type of approach, St. Jude researchers are looking at ways to enhance how these rare but valuable stem cells take hold once transplanted into a new host.

"We recognized that one barrier to improving blood stem cell transplantation is a lack of understanding of how these blood-forming stem cells successfully grow in the challenged environment of transplant. So we set out to identify the genes that control this process," said Shannon McKinney-Freeman, Ph.D., assistant member in the St. Jude Department of Hematology and the study's corresponding author.

"Our hope is to decipher the critical molecular pathways that control the ability of these clinically valuable cells to transplant into a new host," added Per Holmfeldt, formerly a postdoctoral fellow at St. Jude and one of the study's authors.

According to the National Bone Marrow Registry, about 3,000 children require hematopoietic stem cell transplantation each year in the United States. Much of the mortality and morbidity linked to this type of transplantation is due to infection and other complications but could be addressed in some way by protocols that enhance the growth of new blood cells arising from .

After four years of work, a new screening method developed in mouse model systems turned up 17 genes that are novel regulators of hematopoietic stem cell transplantation. Thirteen of these genes had never before been linked to the biology of engraftment of blood-forming stem cells. Engraftment is when new blood-forming stem cells start to grow and produce healthy, mature blood cells.

The scientists were also able to pinpoint the role of the Foxa3 gene, which was shown for the first time to play an important role in repopulating blood-forming stem cells in the experimental system used by the researchers. Investigators found that Foxa3 likely regulates the blood-cell-forming response that takes place under the conditions of stress experienced after transplantation.

"Our functional screen in mice is a first step to enhancing hematopoietic stem . If we are to improve transplant outcomes in patients, we next need to study these identified genes and the molecules they specify in much more detail," McKinney-Freeman said. "The more we understand the full scope of the molecular mechanisms that regulate stable engraftment of blood , the better equipped we will be to develop and clinically test novel therapies to improve health outcomes."

Explore further: Team identifies emergency response system for blood formation

More information: Per Holmfeldt et al. Functional screen identifies regulators of murine hematopoietic stem cell repopulation, The Journal of Experimental Medicine (2016). DOI: 10.1084/jem.20150806

Related Stories

Team identifies emergency response system for blood formation

November 16, 2015
Scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) have determined how the body responds during times of emergency when it needs more blood cells. In a study published in Nature, researchers ...

Source of stem cells used for bone marrow failure treatment varies worldwide

January 12, 2016
Ayami Yoshimi, M.D., Ph.D., of the University of Freiburg, Germany, and colleagues examined the use of peripheral blood stem cells and bone marrow as stem cell sources for hematopoietic stem cell transplantation in patients ...

Scientists see through bones to uncover blood-forming stem cell details

September 24, 2015
A team of scientists at the Children's Research Institute at UT Southwestern (CRI) has become the first to use a tissue-clearing technique to localize a rare stem cell population, in the process cracking open a black box ...

Acceleration of the G1 phase transit during cell division makes human blood stem cells more powerful

July 10, 2015
For the first time, the research group of Prof. Claudia Waskow at the Carl Gustav Carus Faculty of Medicine at Dresden Technical University is now describing a new mechanism in which the length of the G1 phase of the cell ...

Blood vessel cells improve the conversion of pluripotent stem cells to blood lineages

February 9, 2015
Hematopoietic stem cells (HSCs) can differentiate into all of the different types of cells that comprise the blood and immune cell lineages. HSC transplantation is the only effective treatment for certain blood disorders; ...

Study identifies gene involved in blood stem cell replication, movement

April 9, 2008
Researchers at the Joslin Diabetes Center have identified a gene that is responsible for the division and movement of marrow-derived, blood-forming stem cells, a finding that could have major implications for the future of ...

Recommended for you

Scientists reverse aging-associated skin wrinkles and hair loss in a mouse model

July 20, 2018
Wrinkled skin and hair loss are hallmarks of aging. What if they could be reversed?

Enzyme identified as possible novel drug target for sickle cell disease, Thalassemia

July 19, 2018
Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease (SCD). Experiments ...

Mice given metabolite succinate found to lose weight by turning up the heat

July 19, 2018
A team of researchers with members from institutions across the U.S. and Canada has found that giving the metabolite succinate to mice fed a high-fat diet prevented obesity. In their paper published in the journal Nature, ...

Supplement may ease the pain of sickle cell disease

July 19, 2018
(HealthDay)—An FDA-approved supplement reduces episodes of severe pain in people with sickle cell disease, a new clinical trial shows.

Scientists uncover DNA 'shield' with crucial roles in normal cell division

July 18, 2018
Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.

Researchers develop novel bioengineering technique for personalized bone grafts

July 18, 2018
Scientists from the New York Stem Cell Foundation (NYSCF) Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering (SATE). The technique, described in a paper published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.